Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Pharmaceutical market sales value in Turkey 2010-2018

Sales value of the pharmaceutical market in Turkey from 2010 to 2018 (in billion Turkish lira)

by Conor Stewart, last edited Aug 7, 2019
Pharmaceutical market sales value in Turkey 2010-2018 This statistic displays the total sales value of the Turkish pharmaceutical market between 2010 and 2018. In 2018, the pharmaceutical market in Turkey had a total sales value of approximately 31 billion Turkish lira. The value of the pharmaceutical market in Turkey has increased significantly since 2012.
Show more

Sales value of the pharmaceutical market in Turkey from 2010 to 2018 (in billion Turkish lira)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pharmaceutical trends in Europe"
  • Overview
The most important statistics
  • European Pharmaceutical companies
  • Self-medication market
  • Employment
  • Clinical Trials
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.